Farther Finance Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1992825
SAN FRANCISCO, CA
Position in VRTX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,444,905
+$322,947 QoQ
Shares Held
4,922
+3.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#619
of 1,732 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. VRTX ranks #1 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,922 | $2,444,905 | |
| 2 | MRNA |
Moderna, Inc.
|
15,429 | $1,080,492 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
12,088 | $985,292 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
11,241 | $879,833 | |
| 5 | EXEL |
Exelixis, Inc.
|
14,171 | $771,044 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,075 | $670,305 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
15,171 | $591,820 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
7,871 | $450,378 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,444,905 | 4,922 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,121,958 | 4,752 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,004,304 | 4,421 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,328,834 | 3,393 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,293,751 | 2,906 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,391,918 | 2,871 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $970,104 | 2,409 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,070,614 | 2,302 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,083,680 | 2,312 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $349,456 | 836 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $296,215 | 728 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $74,068 | 213 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $51,026 | 145 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $43,164 | 137 | Shares | Sole | 2024-05-14 | |
| 2022-12-31 | $50,247 | 174 | Shares | Sole | 2023-09-12 | |
| No filing history on record for this holder in this stock. | ||||||